Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-04-16

Treatment of diabetes by islet cell transplantation

Obiettivo

The long-term goal of this programme is to cure diabetic patients by implantation of insulin-producing islet cells.
The long term goal of this programme is to prevent the development of chronic complications in diabetic patients by implantation of an insulin producing beat graft cell.
Our working hypothesis is that successful transplantation of beta cell grafts with selected size, composition and function. The biologic properties of beta cell grafts should be characterised and adjusted to the metabolic and immunologic status of the recipient. This type of graft should increase the efficacy of accompanying measures aiming at graft survival and/or metabolic correction.
Since the supply of human beat cels is insufficient for experimental or therapeutic trnasplantation programmes in diabetes, we propose additional core activities for the production of beta graft cells from two alternate sources. The first approach aims at the generation of human beta cells from stem cells which are to be purified frompancreatic duct cells that will be isolatedfrom young donors. The secon approach involves mass isolation of islet or beta cells from foetal porcine pancreata and their encapsulation in bioartificial devices which protect the xenogeneic donor tissue agianst host attack.
The project is based on the observation that purified endocrine islet cell grafts correct the diabetic state in rodents and remain functional across a major histocompatibility barrier without continuous pharmacologic immunosuppression. Implantation of unpurified pancreatic tissue or organs is, on the contrary, markedly less successful in the treatment of diabetes, even under immunosuppressive drug administration. Islet cell preparations also allow quantitative and qualitative assessment of the biologic properties of donor material. This is considered important for constructing metabolically and immunologically adequate grafts. Therefore, purified insulin-producing cell grafts will be prepared from human pancreatic organs and maintained in an islet cell bank. Isolated insulin-producing B cells will be made available to participating research laboratories for studies focusing on the cellular, metabolic and immunologic questions of this programme. After satisfactory quality control, the grafts will be implanted in selected insulin-dependent diabetic patients.

This multinational initiative involves collection of human donor pancreata by participating centres, their shipment to the central facility in Brussels for the standardized production and banking of grafts, and the distribution of quality-tested material to participating hospitals for clinical trial. All stages in the project require interactions between research and clinical departments. Parallel collaborations in research and development focus on medical and technological issues of this programme.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Dati non disponibili

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CON - Coordination of research actions

Coordinatore

The Vrije Universiteit
Contributo UE
Nessun dato
Indirizzo
Laarbeeklaan 103
1090 Brussels
Belgio

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato
Il mio fascicolo 0 0